Archeon Medical, a leading French healthcare technology firm headquartered in Besancon, has successfully closed a multi-million-euro funding round. Led by Bpifrance alongside BNP Paribas and Caisse d’Epargne, this round is instrumental for the company’s long-term strategy to revolutionize emergency medical care globally. The substantial funding will significantly expedite the international rollout of Archeon Medical’s proprietary artificial ventilation monitoring technology, EOlife. EOlife is designed to improve the efficiency of manual ventilation, a critical aspect of emergency and hospital care, with the potential to dramatically boost survival and reduce neurological complications among patients. This strategic investment is not only financial support but a milestone in addressing the inefficacies in current emergency medical response systems, making Archeon a pioneer in manual ventilation monitoring. The company, founded by Alban De Luca and Pierre-Edouard Saillard in 2018, has grounded its technology in years of research, providing it a competitive edge and the potential to become an industry standard. With EOlife already marketed across various international territories, Archeon Medical’s commitment to enhancing emergency care through innovation is set to make a profound global impact.

Healthcare Technology, Financial Services, Emergency Medical Services,France, Global